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Expanded genetic screening in
Caenorhabditis elegans identifies new
regulators and an inhibitory role for
NAD+ in axon regeneration
Kyung Won Kim1‡*, Ngang Heok Tang1, Christopher A Piggott1†,
Matthew G Andrusiak1†, Seungmee Park1†, Ming Zhu1, Naina Kurup1,
Salvatore J Cherra III1§, Zilu Wu1, Andrew D Chisholm1*, Yishi Jin1,2*
1Section of Neurobiology, Division of Biological Sciences, University of California,
San Diego, La Jolla, United States; 2Department of Cellular and Molecular Medicine,
University of California, San Diego, School of Medicine, La Jolla, United States
Abstract The mechanisms underlying axon regeneration in mature neurons are relevant to the
understanding of normal nervous system maintenance and for developing therapeutic strategies
for injury. Here, we report novel pathways in axon regeneration, identified by extending our
previous function-based screen using the C. elegans mechanosensory neuron axotomy model. We
identify an unexpected role of the nicotinamide adenine dinucleotide (NAD+) synthesizing enzyme,
NMAT-2/NMNAT, in axon regeneration. NMAT-2 inhibits axon regrowth via cell-autonomous and
non-autonomous mechanisms. NMAT-2 enzymatic activity is required to repress regrowth. Further,
we find differential requirements for proteins in membrane contact site, components and
regulators of the extracellular matrix, membrane trafficking, microtubule and actin cytoskeleton,
the conserved Kelch-domain protein IVNS-1, and the orphan transporter MFSD-6 in axon regrowth.
Identification of these new pathways expands our understanding of the molecular basis of axonal
injury response and regeneration.
DOI: https://doi.org/10.7554/eLife.39756.001
Introduction
Axon regeneration after injury is an important and conserved biological process in many animals,
involving a large number of genes and pathways (He and Jin, 2016; Mahar and Cavalli, 2018;
Tedeschi and Bradke, 2017). Upon axonal injury, distal axon segments degenerate and segments
proximal to the cell body remain alive and can in certain cases regenerate (Chen et al., 2007;
McQuarrie and Grafstein, 1973; Neumann and Woolf, 1999). Axon regeneration after injury
requires rapid sealing of the damaged plasma membrane (PM) and subsequent formation of growth
cones, leading to regrowth and extension from damaged proximal axons. These cellular changes
involve numerous molecular pathways, starting with rapid calcium influx at injury sites (Ghosh-
Roy et al., 2010; Rishal and Fainzilber, 2014; Wolf et al., 2001), retrograde injury signaling, tran-
scriptional reprogramming to re-structuring of the cytoskeleton and re-organization of the extracel-
lular matrix (ECM) (Blanquie and Bradke, 2018). In the adult mammalian central nervous system
(CNS), axon regeneration is limited, due to the combination of a repressive glial environment and a
lower intrinsic growth capacity of CNS neurons (He and Jin, 2016). The lack of axonal regrowth after
CNS injuries, therefore, impairs functional recovery.
Many approaches have been proposed and tested to promote axon regeneration over the past
decades (David and Aguayo, 1981; He and Jin, 2016; Park et al., 2008). Yet, mechanistic
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understanding of how damaged axons regenerate in a permissive environment remains fragmented.
Since the discovery of functional axon regeneration in the nematode Caenorhabditis elegans
(Yanik et al., 2004), several function-based genetic screens have revealed conserved axon regenera-
tion genes and pathways, notably the highly conserved MAPKKK DLK-1 signaling cascade
(Yan et al., 2009; Chen et al., 2011; Hammarlund et al., 2009; Nix et al., 2014). We previously
reported a distinct set of genes identified from a genetic screen of 654 genes in mechanosensory
axon regeneration (Chen et al., 2011). For example, regulators of microtubule (MT) dynamics play a
rate-limiting role in axon regrowth, consistent with findings from other animal models (Bradke et al.,
2012; Hur et al., 2012). Additional studies reveal other conserved pathways include the RNA-bind-
ing protein CELF/UNC-75 (Chen et al., 2016a), the miRNA and piRNA pathway (Kim et al., 2018;
Zou et al., 2013), the fusogen EFF-1 (Ghosh-Roy et al., 2010; Neumann et al., 2015), and the apo-
ptotic pathway (Pinan-Lucarre et al., 2012). Importantly, the findings from C. elegans are echoed
from similar screening in mammalian neurons (Sekine et al., 2018; Zou et al., 2015).
Here, we report our analysis of 613 additional new genes using the C. elegans mechanosensory
axon regeneration assay. We find new gene classes with inhibitory roles in axon regrowth, such as
the NAD+ salvage pathway and the conserved Kelch-domain protein IVNS-1. We also find several
permissive factors, such as A Disintegrin and Metalloprotease with Thrombospondin repeats
(ADAMTS) proteins, a Rab GTPase RAB-8, and the membrane transporter MFSD-6. We show that
the endoplasmic reticulum (ER)-PM contact site protein Extended Synaptotagmin (ESYT-2) is sensi-
tive to axonal injury, and that Junctophilin (JPH-1) inhibits axon-axon fusion. Our studies of genes
encoding lipid or phospholipid metabolic enzymes indicate extensive functional redundancy. This
expanded screen reinforces several themes from the previous study, such as the inhibitory role of
ECM components and the permissive role of MT stabilization (Chen et al., 2011). Together, our find-
ings highlight the molecular complexity of axon regeneration and provide the genetic framework for
a more comprehensive understanding of axon regeneration.
Results
We screened 613 additional genes representing nine classes of protein function and structure,
selected based on their sequence conservation and the availability of viable genetic mutants with
normal axon development (Figure 1A,B; Figure 1—source data 1). We tested genetic null or strong
loss-of-function mutations in each gene for effects on mechanosensory PLM (Posterior Lateral Micro-
tubule) axon regeneration. In the PLM axon regrowth model, we sever the axon ~50 mm distal from
the cell body in the fourth larval (L4) stage using a femtosecond laser and measure axon regrowth
24 hr post-axotomy in at least 10 animals per strain (Wu et al., 2007). From these 613 genes, we
identified 49 genes promoting PLM regrowth (i.e. showing reduced regrowth in loss-of-function
mutants) and 34 genes inhibiting regrowth (i.e. increased regrowth in loss-of-function mutants)
(Tables 1 and 2; Figure 1—source data 1). As in our previous screen, genes affecting axon
regrowth are found across all functional and structural classes tested (Figure 1B). The percentage of
genes having positive or negative effects on regrowth was similar to that reported in our previous
screen (Chen et al., 2011) (Figure 1—figure supplement 1), suggesting this screen remains far
from saturated. The combined analyses of >1200 genes reinforce the conclusion that regenerative
axon regrowth requires many genetic pathways, most of which are not involved in developmental
axon outgrowth or guidance. Below, we first focus on a set of genes with previously uncharacterized
roles in axon regeneration and then summarize common themes from the expanded screen.
The conserved enzyme NMNAT inhibits axon regeneration
Among genes with significant inhibitory effects on axon regrowth, we identified NMAT-2, a member
of the nicotinamide mononucleotide adenylyltransferase (NMNAT) enzyme family (Figure 2A,B).
NMNAT enzymes catalyze a vital step in NAD+ biosynthesis and confer neuroprotection in several
injury models of flies and mice (Gerdts et al., 2016). In mammalian neurons increasing NMNAT
activity protects against Wallerian degeneration and axon degradation following trophic
factor withdrawal (Mack et al., 2001; Vohra et al., 2010). In C. elegans, overexpression of NMAT-2/
NMNAT protects against neuronal degeneration caused by the toxic mutant ion channel MEC-4(d)
(Calixto et al., 2012), but does not protect against distal axon degeneration after laser axotomy
(Nichols et al., 2016). We found that PLM regrowth was enhanced in two independent nmat-2 null
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Figure 1. Overview and results of expanded axon regrowth screen. (A) Pie chart showing fraction of genes screened displaying significantly reduced or
increased regrowth at 24 hr. Right: representative inverted grayscale images of PLM 24 hr post-axotomy in wild type (black box), and mutants with
reduced (red boxes) or increased regrowth (blue boxes). Orange arrowhead, site of axotomy. (B) Distribution of reduced/increased regrowth mutants
among nine functional or structural gene classes, shown as percentage of genes in each class. See Figure 1—source data 1 for lists of genes in each
class.
DOI: https://doi.org/10.7554/eLife.39756.002
The following source data and figure supplements are available for figure 1:
Source data 1. List of screened genes, reference alleles, and the functional categories.
DOI: https://doi.org/10.7554/eLife.39756.006
Figure supplement 1. The overview and results of axon regrowth screen combined with our previous study.
DOI: https://doi.org/10.7554/eLife.39756.003
Figure supplement 2. Mutants affecting multiple biological processes required for normal axon regrowth.
DOI: https://doi.org/10.7554/eLife.39756.004
Figure supplement 2—source data 1. Each data point in all graphs.
DOI: https://doi.org/10.7554/eLife.39756.005
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Table 1. Mutants displaying reduced PLM regrowth
Gene
name Mutations
Normalized regrowth (24
hr) N
P
value Molecular function
Closest human
Genea
A. Cell Adhesion and ECM
adt-1 cn30 0.75 21 ** ADAM metalloprotease ADAMTS3
adt-3 ok923 0.71 46 ** ADAM metalloprotease ADAMTS2
C05D9.7 ok2931 0.60 28 *** Unknown N/A
dpy-10 e128 0.67 28 ** 5FMC ribosome biogenesis complex PELP1
F35G2.1 ok1669 0.68 27 *** Quiescin sulfhydryl oxidase QSOX1
gly-2 tm839 0.69 16 * Mannosyl-glycoprotein N-acetylglucosaminyltransferases MGAT5
osm-11 rt142 0.72 13 ** Secreted protein N/A
zig-1 ok784 0.68 12 * Basigin BSG
zig-3 ok1476 0.73 18 ** Kazal type serine peptidase inhibitor domain KAZALD1
B. Channels and transporters
abts-1 ok1566 0.74 34 *** Anion exchange protein SLC4A7
mfsd-6 ju833 0.68 15 ** Major facilitator MFSD6
C. Cytoskeleton and motors
fli-1 ky535 0.61 27 *** Actin remodeling protein FLII
mec-12 e1605 0.73 15 * Tubulin a 3 chain TUBA1C
mec-17 ok2109 0.55 14 ** a-Tubulin N-acetyltransferase ATAT1
tba-9 ok1858 0.70 24 ** a-Tubulin TUBA3
vab-10 e698 0.78 11 * Spectraplakin DST
D. Protein kinases and phosphatases
plk-1 or683ts 0.59 13 ** Polo like kinase PLK1
svh-2 tm737 0.68 30 *** Receptor Tyrosine kinase MET
E. Neurotransmission, metabolism, and lipid
cept-2 ok3135 0.68 27 * Choline/ethanolamine phosphotransferase CEPT1
cpr-1 ok1344 0.60 32 *** Cysteine proteinase CTSB
dhhc-11 gk1105 0.75 32 *** Palmitoyltransferase ZDHHC11
eat-3 tm1107 0.74 16 ** Mitochondrial dynamin like GTPase OPA1
npr-20 ok2575 0.49 44 *** G-protein coupled receptor CCKBR/TRHR
ptps-1 tm1984 0.55 27 *** 6-pyruvoyl tetrahydrobiopterin synthase PTS
supr-1 ju1118 0.78 30 ** Unknown N/A
F. Trafficking
jph-1 ok2823 0.77 14 ** Junctophilin JPH1
rab-8 tm2526 0.77 28 ** Ras GTPase RAB8B
rsef-1 ok1356 0.66 17 * Endosomal Rab family GTPase RASEF
G. Signaling and interactions
osm-7 tm2256 0.57 28 ** Unknown N/A
par-2 or373 0.63 47 *** C3HC4-type RING-finger TRIM
rgl-1 ok1921 0.74 30 ** Ral guanine nucleotide dissociation stimulator RGL1
wdfy-3 ok912 0.52 17 *** WD40 and FYVE domain WDFY3
wdr-23 tm1817 0.66 30 *** DDB1 and CUL4 associated factor DCAF11
H. Protein turnover, proteases, cell death
brap-2 ok1492 0.61 62 *** BRCA1-associated protein; zinc ion binding activity BRAP
cdc-48.1 tm544 0.69 19 ** Transitional ER ATPase homolog VCP
ced-9 n1950 0.73 16 * Cell-death inhibitor Bcl-2 homolog BCL2
Table 1 continued on next page
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(0) mutants, tm2905 and ju1512 (Figure 2B,C). A null mutation of NMAT-1, a close paralog, did not
affect PLM regrowth (Figure 2C). nmat-2(0) adult animals are sterile, while nmat-1(0) are fertile, indi-
cating that these two NMNATs may have distinct tissue- or cell-type-specific roles.
To address whether the observed effects of nmat-2(0) are related to NAD+ synthesis, we exam-
ined loss-of-function mutants of other enzymes in the invertebrate NAD+ salvage synthesis pathway
(Figure 2A), including the glutamine-dependent NAD+ synthase QNS-1, nicotinamide riboside
kinase (NRK) NMRK-1, nicotinate phosphoribosyltransferase (NAPRT) NPRT-1, nicotinamidase PNC-1
and PNC-2 (Magni et al., 1999; Vrablik et al., 2009). Among these, only qns-1(0) mutants showed
marginally increased axon regrowth (Figure 2C). NMAT-2 and QNS-1 catalyze the terminal steps of
the NAD+ salvage pathway. Like nmat-2(0), qns-1(0) mutants are sterile (Wang et al., 2015) (this
work), while other single mutants are fertile, suggesting that NMAT-2 and QNS-1 define essential
steps in the biosynthesis of NAD+. To address whether sterility of the animals might contribute to
the observed effects on axon regrowth, we cultured animals on 5’fluoro-2’ deoxyuridine (FUdR) and
found that neither wild type or nmat-1(0) grown in FUdR showed increased PLM regrowth (Fig-
ure 2—figure supplement 1). Additionally, we have previously reported that sterile animals follow-
ing germline ablation do not affect PLM regrowth (Kim et al., 2018). Thus, we conclude that NMAT-
2’s role in axon regrowth is independent of animal fertility.
We next focused on NMAT-2 to define the role of NAD+ pathway in axon regeneration. Using
CRISPR genome editing, we generated a single copy transgene expressing nmat-2(+) under its
endogenous promoter (juSi347). This transgene fully rescued the sterility of nmat-2(0) and restored
the increased axon regrowth in nmat-2(0) mutants to wild-type levels (Figure 2C), confirming that
the increased axon regrowth is due to loss of NMAT-2 function. We then asked in which tissues
NMAT-2 acts to inhibit axon regeneration using transgenic expression of NMAT-2 in the epidermis,
intestine, or mechanosensory neurons (Figure 2—source data 1). Transgenic expression of NMAT-2
in individual tissues was not able to restore axon regeneration in nmat-2(0) to normal (Figure 2D).
Interestingly, the combined expression of NMAT-2 in all three tissues restored normal axon regener-
ation (Figure 2D), and also partially rescued sterility. We conclude that NMAT-2 may act in both
neuronal and non-neuronal cells to inhibit axon regeneration.
Table 1 continued
Gene
name Mutations
Normalized regrowth (24
hr) N
P
value Molecular function
Closest human
Genea
dnj-23 tm7102 0.69 32 ** DNaJ domain (prokaryotic heat shock protein) DNAJC9
fbxc-50 tm5154 0.73 12 * F-box protein N/A
math-33 ok2974 0.64 12 *** Ubiquitin-specific protease USP7
skr-5 ok3068 0.69 12 * S-phase kinase associated protein SKP1
tep-1 tm3720 0.53 36 *** ThiolEster containing Protein; endopeptidase inhibitor
activity
CD109
I. Gene expression and RNA regulation
mec-8 e398 0.23 16 *** RNA binding protein, mRNA processing factor RBPMS
rict-1 mg360 0.58 26 *** Subunit of TORC2 RICTOR
rtcb-1 b gk451 0.58 25 *** tRNA-splicing ligase RtcB homolog RTCB
skn-1 ok2315 0.78 10 * Basic leucine zipper protein NFE2
smg-3 r930 0.68 28 *** Nonsense mediated mRNA decay regulator UPF2
syd-9 ju49 0.47 15 *** Zinc finger E-box binding homeobox ZEB1
tdp-1 ok803 0.70 36 *** TAR DNA-binding protein TARDBP/TDP-43
wdr-5.1 ok1417 0.70 26 *** WD repeat-containing protein WDR5
Genes are classified in nine functional or structural classes. Mutations are genetic or predicted molecular nulls, or partial loss-of-function. Normalized
regrowth is relative to matched same-day controls or to pooled controls. Significant levels (*p<0.05; **p<0.01; ***p<0.001) based on Student’s t-test.
a Closest human gene based on BLASTP score in Wormbase WS263; Ensembl/HGNC symbol.
brtcb-1(gk451) mutant reported to show increased regrowth in the C. elegans motor neurons (Kosmaczewski et al., 2015).
DOI: https://doi.org/10.7554/eLife.39756.007
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Table 2. Mutants displaying increased PLM regrowth
Gene name Mutations Normalized regrowth (24 hr) N P value Molecular function Closest human Genea
A. Cell adhesion and ECM
emb-9 tk75 b 1.37 28 *** Collagen type IV a3 chain COL4A3
epi-1 gm121 1.33 36 *** Laminin LAMA
mig-17 k174 1.24 37 *** ADAM metalloprotease ADAMTS5
ZC116.3 ok1618 1.40 26 *** Cubilin CUBN
B. Channels and transporters
lgc-12 ok3546 1.33 26 ** Serotonin receptor 3E HTR3E
tmc-1 ok1859 1.31 30 ** Transmembrane channel-like protein TMC1
C. Cytoskeleton and motors
ivns-1 ok3171 1.31 18 ** Actin-binding; splicing IVNS1ABP
twf-2 ok3564 1.33 39 ** Twinfilin actin binding protein TWF
nud-1 ok552 1.30 25 ** Nuclear distribution C, Dynein complex regulator NUDC
tba-7 gk787939 1.45 15 *** a-tubulin TUBA
E. Neurotransmission, metabolism, and lipid
nmat-2 tm2905 1.55 38 *** Nicotinamide mononucleotide adenylyltransferase NMNAT1
qns-1 ju1563 1.13 40 * NAD + synthetase NADSYN1
mgl-1 tm1811 1.24 28 ** Glutamate metabotropic receptor GRM3
mgl-3 tm1766 1.32 22 ** Glutamate metabotropic receptor GRM6
npr-25 ok2008 1.27 26 ** Coagulation factor II thrombin receptor F2RL2
ucr-2.3 ok3073 1.41 24 *** Ubiquinol-cytochrome C reductase core protein UQCRC2
F. Trafficking
nex-1 c gk148 1.38 27 *** Annexin ANXA13
nex-2 d ok764 1.23 30 ** Annexin ANXA7
snb-6 tm5195 1.30 38 ** Vesicle associated membrane protein VAMP1
G. Signaling and interactions
drag-1 tm3773 1.52 26 ** Repulsive guidance molecule BMP co-receptor RGMB
ect-2 ku427 1.31 31 ** RhoGEF ECT2
lin-2 e1309 1.31 27 *** Membrane associated guanylate kinase CASK
magi-1 zh66 1.40 29 *** Membrane associated guanylate kinase MAGI2
prmt-5 gk357 1.26 24 ** Protein arginine N-methyltransferase PRMT5
rap-1 tm861 1.33 10 *** Ras small GTPase RAP1
smz-1 ok3576 1.39 13 * PDZ domain-containing protein N/A
trxr-1 tm2047 1.3 31 * Thioredoxin reductase TXNRD2
H. Protein turnover, proteases, cell death
natb-1 ju1405 1.29 14 * N(a)-acetyltransferase 20 NAA20
rnf-5 tm794 1.28 15 * Ring finger protein RNF5
ulp-5 tm3063 1.22 30 *** SUMO specific peptidase SENP7
I. Gene expression and RNA regulation
csr-1 fj54 1.24 38 *** Argonaute AGO1
hda-6 tm3436 1.29 42 *** Histone deacetylase HDAC6
elpc-3 ok2452 1.31 26 *** Elongator acetyltransferase complex subunit ELP3
Genes are classified in nine functional or structural classes. Mutations are genetic or predicted molecular nulls, or partial loss-of-function. Normalized
regrowth is relative to matched same-day controls or to pooled controls. Significant levels (*p<0.05; **p<0.01; ***p<0.001) based on Student’s t-test.
a Closest human gene based on BLASTP score in Wormbase WS263; Ensembl/HGNC symbol.
b emb-9(tk75) mutant reported to be a gain-of-function allele that makes stable EMB-9/Type IV collagen (Kubota et al., 2012).
cnex-1(gk148) mutant reported to show reduced regrowth in the C. elegans motor neurons (Nix et al., 2014).
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In addition to their enzymatic roles, several NMNAT proteins function as molecular chaperones,
including Drosophila NMNAT, mouse NMNAT2, and human NMNAT3 (Ali et al., 2016; Zhai et al.,
2006; Zhai et al., 2008). We therefore tested whether the enzymatic properties of NMAT-2 are
required for inhibition of axon regeneration. Using CRISPR genome editing, we mutated the active
site motif involved in ATP recognition (Zhang et al., 2002) (Figure 2B). This mutant nmat-2(ju1514)
displayed sterility and enhanced regrowth of PLM neurons (Figure 2C), indistinguishable from nmat-
2(0) mutants. Therefore, the role of NMAT-2 in axon regeneration likely requires its enzymatic activ-
ity. Here, we infer that the enhanced axon regeneration in nmat-2(0) reflects sustained low levels of
NAD+.
The neuroprotective effect of NMNAT is cell-autonomous in Drosophila and in mice (Gilley et al.,
2013; Wen et al., 2011). Our finding that NMAT-2 inhibits axon regrowth via several tissues sug-
gests that NMNAT may function via distinct mechanisms for neuroprotection vs. axon regeneration.
The PLM axon is adjacent to the intestine and is enveloped by the surrounding epidermis
(Emtage et al., 2004). Speculatively, NAD+ might activate inhibitory factors in neurons and in sur-
rounding tissues, which act together to repress the axon regenerative response; some of these fac-
tors might regulate cell-cell interaction and signal transduction. In Drosophila, lack of NMNAT also
led to enhanced sensory axon regeneration (Chen et al., 2016b). Together, these data suggest con-
served roles of NMNAT in axon regeneration. Future work will be required to dissect specific mecha-
nisms by which NMNAT inhibits axon regeneration.
Differential roles and functional redundancy of ER-PM contact site
components in axon regeneration
Membrane contact sites (MCSs) are regions where membranes from two organelles or an organelle
and the PM are held together by protein tethers, most of which are conserved from yeast to mam-
mals (Phillips and Voeltz, 2016; Saheki et al., 2016). MCSs can coordinate activities such as calcium
entry or lipid transfer between membranes. Calcium entry via voltage-gated Ca2+ channels in the
PM is critical for PLM axon regeneration (Ghosh-Roy et al., 2010). Additionally, MCSs between the
PM and ER might be involved in lipid addition to the PM during rapid extension of regrowing axons
(Hausott and Klimaschewski, 2016). We therefore examined mutants affecting conserved ER-PM
MCS components such as Junctophilin, Extended synaptotagmin (E-Syt), Anoctamins, and OxySterol
Binding Proteins (OSBP).
Junctophilins are multi-pass transmembrane proteins that are localized to ER-PM contacts in
excitable cells, where they couple PM- and ER-localized calcium channels (Landstrom et al., 2014).
JPH-1 is the sole Junctophilin in C. elegans (Yoshida et al., 2001) (Figure 3A). We observed that
jph-1(ok2823) mutants, likely null, exhibited a significantly increased rate of reconnection or fusion
between the regrowing axon and distal fragment (Figure 3B). Axons that did not reconnect in jph-1
mutants exhibited reduced axon regeneration, compared to controls (Figure 3C). As reconnected
axons were not measured for regrowth analysis, the reduced regrowth in jph-1 mutants might be
due to an overrepresentation of poorly growing axons. Axon-axon fusion requires the fusogen EFF-1
(Ghosh-Roy et al., 2010; Pe´rez-Vargas et al., 2014) and a phosphoserine-mediated apoptotic cell
engulfment pathway (Neumann et al., 2015). We analyzed eff-1; jph-1 double mutants and found
that the enhanced reconnection in jph-1 was greatly reduced (Figure 3B). Drosophila Junctophilin-
like molecule functions in apoptotic cell removal (Gronski et al., 2009). These observations suggest
JPH-1-mediated contacts may restrict axon-axon fusion, dependent on eff-1.
Extended synaptotagmins (E-Syt) are a family of proteins containing multiple C2 domains
(Figure 3D) that have been shown to tether the ER to the PM (Giordano et al., 2013) and are impli-
cated in membrane lipid transfer (Saheki et al., 2016; Yu et al., 2016). ESYT-2 is the sole E-Syt in C.
elegans and is most closely related to human E-Syt2 and E-Syt3 (Figure 3D). We found that esyt-2
showed wide expression in the nervous system (Figure 3—figure supplement 1). In the mechano-
sensory neuron cell body, full-length GFP-ESYT-2 showed a punctate pattern, colocalizing with an
ER marker PISY-1 (Rolls et al., 2002) at the peripheral ER (Figure 3E). In uninjured axons, ESYT-2
was distributed intermittently (Figure 3F; upper panel). Strikingly, upon axon injury, axonal ESYT-2
d nex-2(bas4) mutant reported to show normal regrowth in the C. elegans motor neurons (Nix et al., 2014).
DOI: https://doi.org/10.7554/eLife.39756.008
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Figure 2. NMNAT/NMAT-2 inhibits PLM axon regrowth via its catalytic domain. (A) Overview of NAD+ salvage biosynthesis pathway. Top, key
enzymes; Bottom, C. elegans orthologs (Shaye and Greenwald, 2011). (B) Top, nmat-2 gene structure and mutant alleles. NMAT-2 contains an
NMNAT domain. nmat-2(ju1514) point mutation and nmat-2(ju1512) deletion alleles were generated using CRISPR-Cas9 genome editing. Bottom,
sequence alignment of the active site of NMNAT domain of C. elegans NMAT-2 (accession number: NP_492480.1; amino acids 4–14) with human
NMNAT1–3 (NP_073624.2, NP_055854, NP_001307441) and C. elegans NMAT-1 (NP_510010.2). Sequences were analyzed using Clustal Omega. (C)
Normalized regrowth 24 hr post-axotomy in mutants lacking genes encoding enzymes in the NAD+ biosynthesis pathway. Statistics, Student’s t-test
with same day controls. For the statistical test of transgene analysis, one-way ANOVA followed by Tukey’s multiple comparison test. (D) PLM axon
regrowth 24 hr post-axotomy in transgenic animals expressing nmat-2(+) driven by tissue-specific promoters for mechanosensory neurons (Pmec-4),
epidermis (Pcol-12) or intestine (Pmtl-2) in a nmat-2(ju1512) background. One-way ANOVA followed by Tukey’s multiple comparison test. Data are
shown as mean ± SEM. n, number of animals shown within columns. ns, not significant; *p<0.05; **p<0.01; ***p<0.001.
DOI: https://doi.org/10.7554/eLife.39756.009
The following source data and figure supplement are available for figure 2:
Source data 1. Each data point in Figure 2C,D.
DOI: https://doi.org/10.7554/eLife.39756.011
Figure supplement 1. nmat-1 show no defect in PLM axon regrowth even when its germline is defective.
DOI: https://doi.org/10.7554/eLife.39756.010
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Figure 3. Select ER-PM membrane contact site proteins are required for axon regeneration and are sensitive to injury. (A) Junctophilin-1 protein
structure. From top to bottom: C. elegans JPH-1 (NP_492193.2), its Drosophila ortholog JP (NP_523525.2), and human ortholog JPH1 (NP_065698.1).
Junctophilins contain N-terminal MORN (Membrane Occupation and Recognition Nexus) repeats (green) and a C-terminal transmembrane domain
(blue). C. elegans deletion allele is indicated above (ok2823). (B) Percentage of axons that exhibit fusion between the regrowing axon and distal
fragment 24 hr post-axotomy. Upper image shows a regrowing axon that has not fused with the distal fragment in a wild-type animal. Lower image
shows fusion between the regrowing axon and the distal fragment in a jph-1(ok2823) animal. Fisher’s exact test. *p<0.05; **p<0.01. (C) Normalized
regrowth 24 hr post-axotomy in mutants lacking selected genes encoding ER-PM MCS proteins. Data are shown as mean ± SEM. n, number of animals
shown within columns. Student’s t-test with same day controls. ns, not significant; *p<0.05; **p<0.01. (D) E-Syt protein structure. From top to bottom:
C. elegans ESYT-2 and its human orthologs E-Syt2, E-Syt3, and E-Syt1 (NP_065779.1, NP_114119.2, NP_056107.1, respectively). Amino acid length is
indicated to the right of each protein. E-Syt proteins contain N-terminal hydrophobic regions (blue), SMP (Synaptotagmin-like Mitochondrial and lipid-
binding Protein) domains (yellow), and C-terminal C2 domains (red). C. elegans deletion allele is indicated above (ju1409). (E) Images of the PLM cell
body and surrounding neurites. Left, GFP::PISY-1 ER marker; Middle, mKate2::ESYT-2 driven by the mec-4 promoter; Right, Image overlays. Images
show single slices taken at 1 mm intervals. (F) Representative inverted grayscale images of GFP::ESYT-2 in the axon of the PLM neuron before and
immediately after axotomy (upper and lower panels, respectively). Site of laser axotomy indicated by asterisk; puncta indicated by arrowheads.
DOI: https://doi.org/10.7554/eLife.39756.012
The following source data and figure supplement are available for figure 3:
Source data 1. Each data point in Figure 3C.
DOI: https://doi.org/10.7554/eLife.39756.014
Figure supplement 1. esyt-2 is widely expressed in the nervous system.
DOI: https://doi.org/10.7554/eLife.39756.013
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condensed into small puncta almost immediately (<1 s) (Figure 3F; lower panel). As axon injury trig-
gers a rapid rise in axonal calcium (Ghosh-Roy et al., 2010), we speculate that the injury-induced
Ca2+ transient triggers ESYT-2 relocalization to axonal ER-PM contact sites. This is consistent with
the observation that vertebrate E-Syt1 can localize to ER-PM contact sites following an increase in
cytosolic calcium (Giordano et al., 2013; Idevall-Hagren et al., 2015). We generated esyt-2 null
mutants by genome editing (Figure 3D). These mutant animals were indistinguishable from wild-
type animals in growth rate, body morphology, and exhibited normal axon development and
regrowth (Figure 3C). Thus, while ESYT-2 undergoes temporal changes in response to axon injury, it
does not appear to be essential for axon regrowth.
The Anoctamin protein family function as tethers at ER-PM contact sites in yeast (Manford et al.,
2012; Wolf et al., 2012). C. elegans has two orthologs, ANOH-1 and ANOH-2. ANOH-1 is
expressed in mechanosensory neurons and acts together with the apoptotic factor CED-7 to pro-
mote phosphatidylserine exposure in the removal of necrotic cells (Li et al., 2015). ced-7(0) reduces
PLM axon regrowth (Neumann et al., 2015). However, we found that loss of function in anoh-1 or
anoh-2, or the anoh-1; anoh-2 double mutant, did not affect PLM axon regeneration (Figure 3C).
The eukaryotic OSBP and OSBP-related (ORP) family of MCS-localized lipid transfer proteins
includes multiple members. ORP5/8 act as tethers at ER-PM MCSs where they mediate PI4P/Phos-
phatidylserine counter-transport, while OSBP and the other ORPs function at different MCSs
(Chung et al., 2015). We tested the four C. elegans homologs individually as well as a quadruple
mutant. Each obr single mutant displayed normal regeneration, and the quadruple mutant displayed
a significant decrease in axon regrowth (Figure 3C). While the expression pattern and action site of
these OBR proteins remain to be determined, our finding is consistent with the known redundancy
within the OBR family (Kobuna et al., 2010).
Altogether, the above analysis echoes a recent study in yeast where elimination of multiple MCS
components did not impair ER-PM sterol exchange (Quon et al., 2018), highlighting the challenge
to tease apart the functional redundancy of MCS proteins in biological processes.
Lipid metabolic enzymes likely have extensive functional redundancy in
axon regrowth
Lipids are essential components of membranes and regulate many biological functions including
energy storage and lipid signaling. In C. elegans, the majority of triglyceride is obtained from the
diet, and lipogenesis accounts for less than 10% of stored body fat (Srinivasan, 2015). Lipolysis is
required for cellular uptake or release of fatty acids and glycerol (Zechner et al., 2012). Classical
‘neutral’ lipolysis involves at least three different lipases: ATGL (adipose triglyceride lipase), HSL
(hormone sensitive lipase), and MGL (monoglyceride lipase). ATGL requires a coactivator protein,
CGI-58/ABHD5. C. elegans encodes a single ATGL (ATGL-1), three CGI-58/ABHD5 (ABHD-5.2,
ABHD-5.3, and LID-1), a single HSL (HOSL-1), but lacks MGL by sequence homology (Zechner et al.,
2012). We tested single mutants for all these genes and double or triple mutants for ABHD (a/b
hydrolase domain) genes and observed no detectable effects in PLM axon regrowth (Figure 4A).
Triglycerides can also be hydrolyzed through autophagy-mediated degradation of lipid droplets
by some lysosomal acid lipases, termed lipophagy or ‘acid’ lipolysis (Singh et al., 2009). C. elegans
lysosomal lipases (LIPL-1, LIPL-3, and LIPL-4), autophagy proteins (LGG-1 and LGG-2), and transcrip-
tion factors (HLH-30/TFEB and MXL-3/MXL) act in lipophagy (Folick et al., 2015; O’Rourke and
Ruvkun, 2013). Two nuclear hormone receptors NHR-49/PPARa and NHR-80/HNF4a are reported
to regulate LIPL-4 (Folick et al., 2015). We found that single mutants for all these genes showed
normal PLM regrowth (Figure 4B), suggesting that lipolysis may not play an essential role in PLM
axon regeneration.
The Kennedy pathway synthesizes the most abundant phospholipids in eukaryotic membranes,
phosphatidylcholine (PC) and phosphatidylethanolamine (PE) (Gibellini and Smith, 2010), and
involves conserved enzymes catalyzing a series of consecutive reactions (Figure 4C). Of all mutants
affecting individual enzymes in the Kennedy pathway, we found that cept-2 null mutants showed a
significant reduction in axon regrowth (Figure 4D). In testing functional redundancy between cept-1
and cept-2, we found double mutants to be embryonic or larval lethal (data not shown), preventing
further analysis. Definitive conclusions will require tissue-specific and temporal manipulation of this
pathway. Overall, our analysis suggests that the Kennedy pathway may affect axon regeneration.
Kim et al. eLife 2018;7:e39756. DOI: https://doi.org/10.7554/eLife.39756 10 of 31
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The conserved NS1A-BP ortholog IVNS-1 inhibits axon regrowth
Among other conserved proteins, we identified the BTB-Kelch family protein IVNS-1 (Influenza Virus
NS1A binding protein/NS1A-BP) as an inhibitor of axon regrowth. BTB/POZ (Broad-Complex, Tram-
track, and Bric-a-Brac/Poxvirus and Zinc finger) domain and Kelch repeats function in a wide variety
of biological processes including gene expression, protein ubiquitination, and cytoskeleton binding
(Dhanoa et al., 2013). Human NS1A-BP was originally identified based on interaction with the influ-
enza A virus via its Kelch domain (Wolff et al., 1998) (Figure 5A) and was later found to interact
with actin filaments (Perconti et al., 2007) and RNA binding proteins, including heterogeneous
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Figure 4. PLM axon regeneration involves membrane lipid biosynthesis pathway. (A) Normalized PLM axon regrowth 24 hr post-axotomy in
mutants affecting neutral lipolysis. (B) Normalized PLM axon regrowth 24 hr post-axotomy in mutants affecting acid lipolysis. (C) Overview of C.elegans
Kennedy pathway for de novo biosynthesis of PE and PC, the major phospholipids in the PM. (D) Normalized PLM axon regrowth 24 hr post-axotomy in
mutants lacking select genes encoding enzymes in the Kennedy pathway. Data are shown as mean ±SEM. n, number of animals shown within columns.
Student’s t-test with same day controls. ns, not significant; *p<0.05.
DOI: https://doi.org/10.7554/eLife.39756.015
The following source data is available for figure 4:
Source data 1. Each data point in Figure 4A,B,D.
DOI: https://doi.org/10.7554/eLife.39756.016
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Figure 5. The Kelch-domain protein IVNS-1 inhibits axon regeneration. (A) ivns-1 gene structure. Left: Loss-of-function alleles are indicated below
(gk252 and ok3171). Right: Alignment of the C. elegans IVNS-1 (NP_510109.1) with its human ortholog IVNS1ABP (NP_006460.1) and mouse ortholog
ND1-L (NP_473443.2). Number indicates percentage identity of protein sequences. Sequences were analyzed using Clustal Omega. (B) Normalized PLM
axon regrowth 24 hr post-axotomy in mutants of Kelch-domain proteins. Data are shown as mean ±SEM. n, number of animals shown within columns.
Student’s t-test with same day controls. ns, not significant; *p<0.05; **p<0.01; ***p<0.001. Right: representative inverted grayscale images of PLM 24 hr
post-axotomy. Scale bar, 25 mm. (C) Normalized PLM axon regrowth 6 hr post-axotomy. Data are shown as mean ±SEM. One-way ANOVA followed by
Tukey’s multiple comparison test. n, number of animals shown within columns. **p<0.01. (D) Percentage of axons with growth cones (GCs) 6 hr post-
axotomy. n, Number of animals shown below columns. Fisher’s exact test. ns, not significant.
DOI: https://doi.org/10.7554/eLife.39756.017
The following source data is available for figure 5:
Source data 1. Each data point in Figure 5B,C.
DOI: https://doi.org/10.7554/eLife.39756.018
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nuclear ribonucleoprotein and splicing factors (hnRNPs) and RNA helicase (Tsai et al., 2013). C. ele-
gans IVNS-1 has the same overall domain organization as NS1A-BP (Figure 5A).
We analyzed two independent ivns-1 mutants (gk252 and ok3171) and observed increased axon
regrowth, which was restored to control levels following transgenic expression of ivns-1 driven by its
own promoter (Figure 5A,B). ivns-1 mutants showed increased regrowth as early as 6 hr post-injury
(Figure 5C), while growth cone formation in ivns-1 mutants was normal (Figure 5D). The effects of
ivns-1 on axon regrowth appeared to be unique, as mutants in two other BTB-Kelch proteins kel-8
and kel-20 displayed normal regrowth (Figure 5B). Whether the function of IVNS-1 involves actin
cytoskeleton or RNA regulation remains to be determined.
Overview of common themes
Complex roles of basement membrane ECM and ADAMTSs
ECM plays diverse roles in axon regeneration (Barros et al., 2011). In C. elegans, neuronal pro-
cesses are closely associated with basement membrane (BM) (White et al., 1976), which is a thin,
specialized ECM adjacent to epithelial tissues (Jayadev and Sherwood, 2017). We previously
reported that BM components SPON-1/F-spondin and PXN-2/Peroxidasin inhibit axon regrowth
(Chen et al., 2011; Gotenstein et al., 2010). We further analyzed mutants of essential BM structural
components and found that a loss-of-function mutant (gm121) of EPI-1/Laminin a and a gain-of-func-
tion mutant (tk75) of EMB-9/Type IV collagen (Kubota et al., 2012) both showed enhanced
regrowth (Figure 1—figure supplement 2A), supporting defined roles of specific BM components
in axon regrowth.
ADAMTS proteins are secreted metalloproteases and act as key ECM remodeling enzymes
(Tang, 2001). In the mammalian nervous system, ADAMTS4 promotes axon regeneration and recov-
ery after spinal cord injury, by digesting chondroitin sulfate proteoglycans (CSPGs), which are known
to be prominent inhibitory components of the glial scar (Tauchi et al., 2012). In C. elegans, multiple
chondroitin proteoglycans are expressed, but are not sulfated (Olson et al., 2006). The PLM axon is
enveloped by the surrounding epidermis (Emtage et al., 2004) and is not in direct contact with the
BM after embryogenesis. However, regrowing PLM axons may come in contact with the BM during
regrowth. We tested null mutants in all five ADAMTS homologs and found that ADT-1 and ADT-3
promote and MIG-17 inhibits PLM axon regrowth (Figure 1—figure supplement 2A). These results
suggest opposing roles for ADAMTS family members in PLM axon regrowth. ADT-1 and ADT-3 may
normally degrade inhibitory BM such that their deficiency leads to elevated BM and impairs axonal
regrowth. In contrast, MIG-17 may degrade permissive BM (for example, Type IV collagen) such that
its deficiency leads to elevated stable Type IV collagen and enhances axonal regrowth. Together,
these data indicate the complex roles of ECM components and ADAMTSs.
Permissive role of Rab GTPase RAB-8 and inhibitory role of annexin proteins
NEX-1 and NEX-2 in axon regeneration
We previously showed that genes implicated in endocytosis of synaptic vesicles (e.g., unc-57/endo-
philin) or membrane trafficking (rsef-1/RASEF) are required for axon regeneration (Chen et al.,
2011). Here, we tested additional membrane-trafficking factors, especially the Rab small GTPases.
Trafficking of secretory vesicles from the Golgi is partly regulated by Rab8 (Stenmark, 2009), and
trafficking of recycling endosomes is regulated by Rab11 (Ascan˜o et al., 2009). Lack of Rab8 results
in decreased neurite outgrowth in embryonic hippocampal neurons (Huber et al., 1995). C. elegans
RAB-8 has been implicated in membrane trafficking in ciliated neurons (Kaplan et al., 2010). We
found that RAB-8 was required for PLM axon regrowth, whereas RAB-11.2 showed no impact (Fig-
ure 1—figure supplement 2B), suggesting that post-Golgi vesicle trafficking, rather than endosome
recycling, may be important for axon regrowth.
The Annexins are calcium-dependent phospholipid-binding proteins (Monastyrskaya et al.,
2007) with a wide variety of roles in membrane biology (Mirsaeidi et al., 2016) and plasma mem-
brane repair/resealing (Boye and Nylandsted, 2016). C. elegans has four Annexins (NEX-1/–2/ 3/–
4) (Daigle and Creutz, 1999); and NEX-1 was shown to promote GABAergic motor neuron regener-
ation (Nix et al., 2014). We found that NEX-1 and NEX-2 have an inhibitory role on PLM regrowth,
whereas NEX-3 and NEX-4 have no impact (Figure 1—figure supplement 2B). These results suggest
cell-type-dependent roles of Annexins in regrowth.
Kim et al. eLife 2018;7:e39756. DOI: https://doi.org/10.7554/eLife.39756 13 of 31
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Further evidence for permissive roles of the MT cytoskeleton in axon
regeneration
Precise regulation of MT dynamics is a critical factor in axon regrowth (Blanquie and Bradke, 2018;
Tang and Chisholm, 2016). Our previous studies identified EFA-6 as an intrinsic inhibitor of
regrowth by acting as an axonal MT-destabilizing factor (Chen et al., 2015; Chen et al., 2011). We
and others have also reported that MT post-translational modifications have differential roles in axon
regeneration (Cho and Cavalli, 2012; Ghosh-Roy et al., 2012). MT stabilization is linked to acetyla-
tion of a-tubulins (Janke and Montagnac, 2017) and has been shown to improve regrowth; for
example, pharmacological MT stabilization by Paclitaxel or Epothilone B promotes axon regrowth in
multiple models (Chen et al., 2011; Ruschel et al., 2015; Sengottuvel et al., 2011). Here, we
tested two a-tubulin acetyltransferases, MEC-17 and ATAT-2, which acetylate the a-tubulin MEC-12
that is enriched in mechanosensory neurons (Akella et al., 2010). We found that MEC-17, but not
ATAT-2, was required for normal axon regrowth (Figure 1—figure supplement 2C). mec-17; atat-2
double mutants showed reduced axon regrowth resembling the mec-17 single mutant (Figure 1—
figure supplement 2C), suggesting that MEC-17-dependent acetylated MTs are permissive for axon
regrowth. In addition, the HDAC orthologs HDA-3 and HDA-6 inhibit axon regrowth (Chen et al.,
2011) (Table 2). HDAC family proteins, which can deacetylate MTs and other targets, have been
shown to be involved in mammalian axon regeneration (Cho and Cavalli, 2012). Overall, our results
support a pro-regenerative role for acetylated MTs in axon regrowth.
An increasing notion is that isotypes of tubulins influence MT composition and stability (Tang and
Jin, 2018). PLM axons contain predominantly unusual 15 MT filaments made of MEC-7/b-tubulin
and MEC-12/a-tubulin, and also express multiple tubulin isotypes (Kaletsky et al., 2018;
Lockhead et al., 2016) that likely contribute to 11 protofilaments. We found that loss of function in
mec-12 or tba-9 resulted in reduced regrowth (Figure 1—figure supplement 2D). In contrast, loss
of function in tba-7 showed enhanced regrowth. A recent study that examined the neurite growth of
mechanosensory neurons has proposed that TBA-7/ a -tubulin likely functions as a destabilizing fac-
tor for MTs (Zheng et al., 2017). Our observation is consistent with this proposal, and supports the
general role of stabilized MTs in promoting axon regrowth.
Roles for actin filament regulators in axon regeneration
Growth cone formation is an important initial stage of axon regeneration and involves extensive
remodeling of actin filaments (Gomez and Letourneau, 2014). Actin-binding proteins can promote
actin filament assembly or disassembly, for example, Gelsolin severs actin filaments to promote dis-
assembly (Klaavuniemi et al., 2008; Liu et al., 2010), while Twinfilin binds to the ADP-actin mono-
mers and prevents their assembly into filaments (Moseley et al., 2006; Palmgren et al., 2002). Of
the three Gelsolin-related proteins in C. elegans, gsnl-1 and viln-1 null mutants showed normal
regrowth while partial loss-of-function mutants of fli-1 displayed reduced PLM axon regrowth (Fig-
ure 1—figure supplement 2E). In contrast, lack of the Twinfilin homolog TWF-2 increased axon
regrowth. Although both Gelsolin and Twinfilin can promote actin filament disassembly, they may
have differential roles in regenerating C. elegans axons.
Novel ion channels and transporters involved in PLM axon regeneration
Neuronal activity plays a significant role in axon regeneration in vertebrates and invertebrates
(Chen et al., 2011; Ghosh-Roy et al., 2010; Lim et al., 2016; Tedeschi et al., 2016). Our prior
screen tested 54 genes encoding channels and transporters and overall was consistent with neuronal
excitability promoting PLM regrowth. Here, we examined an additional 58 channel or transporter
genes (Figure 1—source data 1). We found several new genes in which loss-of-function mutation
results in enhanced regeneration, including the sodium-sensitive channel tmc-1
(Chatzigeorgiou et al., 2013) and an acetylcholine receptor alpha subunit (CHRNA6) lgc-12
(Cohen et al., 2014) (Table 2). Additionally, we found that MFSD-6, a member of the Major Facilita-
tor Superfamily Domain (MFSD) family, promotes PLM regrowth (Figure 1—figure supplement 2F).
MFSD family proteins have 10–12 transmembrane regions (Yan, 2015); some mediate nutrient trans-
port across the blood-brain barrier (Ceder et al., 2017; Perland et al., 2017), but most are of
unknown function. C. elegans MFSD-6 was previously identified as a regulator of motor circuit activ-
ity and mfsd-6(0) mutants are resistant to inhibitors of cholinesterase (McCulloch et al., 2017). mfsd-
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6 is expressed in most neurons, including mechanosensory neurons (Ogurusu et al., 2015). Loss-of-
function mutants of mfsd-6 exhibited reduced axon regrowth, which was rescued by
expressing wild type mfsd-6 under a pan-neuronal promoter (Figure 1—figure supplement 2F). As
mechanosensory neurons are not thought to be cholinergic, yet other mutants of cholinergic signal-
ing (e.g. cha-1/ChAT, unc-17/VChAT) are defective in axon regrowth (Chen et al., 2011), these data
suggest a possible neuronal, but cell non-autonomous, role for acetylcholine signaling to be permis-
sive for PLM regrowth.
Discussion
Functional screening for axon regeneration phenotypes is a powerful approach to identify novel reg-
ulators of axon regrowth after injury. C. elegans PLM axons exhibit robust response to injury, and
therefore allow efficient screening of positive and negative regulators of regrowth. In this work we
have nearly doubled the number of genes tested using genetic mutations and the PLM regeneration
assay, taking the total number of genes screened to 1267. We expanded some gene classes previ-
ously analyzed in depth (e.g. kinases, ECM components, ion channels, and transporters) and have
also specifically targeted several pathways not addressed in our earlier screen, such as NAD+ biosyn-
thesis, MCS components, lipid metabolism, and actin regulators. Interestingly, both MCS compo-
nents and lipid metabolism tested display a high degree of genetic redundancy, such that single
mutants only occasionally display regeneration defects, and compound mutant strains are required
to assess functional requirements. Nevertheless, our findings suggest that ER-PM contact sites may
be regulated by axon injury and that phospholipid synthesis may be critical for axon regeneration.
Further work will be required to define whether these pathways play a role in lipid addition to the
regrowing axon membrane or a more general signaling role.
Several axon regeneration screens have now been reported in C. elegans and the results may be
compared to assess reproducibility and generalizability of the results. The present work and our
prior screen (Chen et al., 2011) analyzed the effect of genetic mutations on PLM axon regeneration.
In contrast, other studies have used RNAi or genetic mutants to analyze motor neuron regeneration
(Nix et al., 2014). Differing results between the two screens (e.g. the opposite requirement for nex-
1 in PLM and motor neurons) may reflect cell-type-specific roles of the regulators in axon regenera-
tion. A recent genome-wide in vitro axon regeneration screen in mouse cortical neurons revealed
significant overlap with orthologous genes identified from C. elegans screen despite differences in
neuron types, species, and experimental methods (Chen et al., 2011; Nix et al., 2014;
Sekine et al., 2018), suggesting significant conservation of regenerative mechanisms.
Our screen approach is based on candidates and not random mutagenesis, and thus classical esti-
mates of genetic saturation do not apply. However, it is notable that the frequency of positive and
negative hits in the current screen does not differ from our previous screen. Our prior screen
included many previously well-studied axon guidance and outgrowth pathways and thus might have
been enriched for functionally important factors, but the present analysis suggests many genes not
previously associated with the nervous system (e.g. ptps-1, tep-1, brap-2) also have functionally
important roles in regrowth. One trend is that fewer mutants with dramatically reduced regrowth
(<30% of wild type, such as dlk-1, unc-75, sdn-1) were identified, and thus the number of genes
essential for initiation of regrowth may be limited. On the other hand, the present screen identified
new mutants with drastically enhanced regrowth (>140% of wild type, such as efa-6 and pxn-2 from
previous screen and nmat-2 and drag-1 from this screen). Interestingly, a recent genome-wide
screen for enhanced regrowth in mouse cortical neurons reported a positive hit rate of 3%
(Sekine et al., 2018), whereas we find 3.9% of genes displayed significantly elevated axon regrowth.
The frequency of axon regrowth phenotypes may therefore be consistent across screening
platforms.
Materials and methods
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Reagent type
(species) or resource Designation Source or reference Identifiers
Additional
information
Bacterial strain E. coli: OP50 Caenorhabditis
Genetics Center
RRID:
WB-STRAIN:OP50
Genetic reagent
(C. elegans)
Strain wild
type N2
Caenorhabditis
Genetics Center
RRID:WB-STRAIN:N2_
(ancestral)
Genetic reagent
(C. elegans)
CZ10969: Pmec-7-GFP(muIs32) II Considered as
‘WT’ in many
axotomy
experiments
Genetic reagent
(C. elegans)
CZ10175: Pmec-4-GFP(zdIs5) I Considered
as ‘WT’ in many
axotomy
experiments
Genetic reagent
(C. elegans)
CZ25411: nmat-2(ju1512) I/hT2 I, III;
Pmec-7-GFP(muIs32) II
Genetic reagent
(C. elegans)
CZ25415: nmat-2(ju1514) I/hT2 I, III;
Pmec-7-GFP(muIs32) II
Genetic reagent
(C. elegans)
CZ17633: nmat-2(tm2905) I/hT2 I, III;
Pmec-7-GFP(muIs32) II
Genetic reagent
(C. elegans)
CZ24324: Pmec-7-GFP(muIs32) II;
qns-1(ju1563) IV/mIs11 sd IV
Genetic reagent
(C. elegans)
CZ25642: Pmec-4-GFP(zdIs5) I;
Pmec-7-GFP(muIs32) II
Genetic reagent
(C.elegans)
CZ25534: nmrk-1(ok2571) I;
Pmec-7-GFP(muIs32) II
Genetic reagent
(C. elegans)
CZ24241: Pmec-4-GFP(zdIs5) I;
nprt-1(tm6342) IV
Genetic reagent
(C. elegans)
CZ24242: Pmec-4-GFP(zdIs5) I;
pnc-1(tm3502) IV
Genetic reagent
(C. elegans)
CZ24802: Pmec-4-GFP(zdIs5) I;
pnc-2(tm6438) IV
Genetic reagent
(C. elegans)
CZ25466: Pmec-7-GFP(muIs32) II;
juSi347[nmat-2 gDNA] IV
Genetic reagent
(C. elegans)
CZ25469: nmat-2(tm2905) I;
Pmec-7-GFP(muIs32) II;
juSi347[nmat-2 gDNA] IV
Genetic reagent
(C. elegans)
CZ26216: Pmec-7-GFP(muIs32) II;
Ex[Pmec-4-nmat-2(juEx7834)]
Genetic reagent
(C. elegans)
CZ26217: Pmec-7-GFP(muIs32) II;
Ex[Pmec-4-nmat-2(juEx7835)]
Genetic reagent
(C. elegans)
CZ26220: Pmec-7-GFP(muIs32) II;
Ex[Pcol-12-nmat-2(juEx7838)]
Genetic reagent
(C. elegans)
CZ26221: Pmec-7-GFP(muIs32) II;
Ex[Pcol-12-nmat-2(juEx7839)]
Genetic reagent
(C. elegans)
CZ26218: Pmec-7-GFP(muIs32) II;
Ex[Pmtl-2-nmat-2(juEx7836)]
Genetic reagent
(C. elegans)
CZ26219: Pmec-7-GFP(muIs32) II;
Ex[Pmtl-2-nmat-2(juEx7837)]
Genetic reagent
(C. elegans)
CZ26222: nmat-2(ju1512) I/hT2 I, III;
Pmec-7-GFP(muIs32) II;
Ex[Pmec-4-nmat-2(juEx7840)]
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Genetic reagent
(C. elegans)
CZ26223: nmat-2(ju1512) I/hT2 I, III;
Pmec-7-GFP(muIs32) II;
Ex[Pmec-4-nmat-2(juEx7841)]
Genetic reagent
(C. elegans)
CZ26224: nmat-2(ju1512) I/hT2 I, III;
Pmec-7-GFP(muIs32) II;
Ex[Pcol-12-nmat-2(juEx7842)]
Genetic reagent
(C. elegans)
CZ26225: nmat-2(ju1512) I/hT2 I, III;
Pmec-7-GFP(muIs32) II;
Ex[Pcol-12-nmat-2(juEx7843)]
Genetic reagent
(C. elegans)
CZ26310: nmat-2(ju1512) I/hT2 I, III;
Pmec-7-GFP(muIs32) II;
Ex[Pmtl-2-nmat-2(juEx7836)]
Genetic reagent
(C. elegans)
CZ26311: nmat-2(ju1512) I/hT2 I, III;
Pmec-7-GFP(muIs32) II;
Ex[Pmtl-2-nmat-2(juEx7837)]
Genetic reagent
(C. elegans)
CZ26332: nmat-2(ju1512) I/hT2 I, III;
Pmec-7-GFP(muIs32) II;
Ex[Pmtl-2, col-12::nmat-2(juEx7853)]
Genetic reagent
(C. elegans)
CZ26333: nmat-2(ju1512) I/hT2 I, III;
Pmec-7-GFP(muIs32) II;
Ex[Pmtl-2, col-12::nmat-2(juEx7854)]
Genetic reagent
(C. elegans)
CZ26285: nmat-2(ju1512) I/hT2 I, III;
Pmec-7-GFP(muIs32) II;
Ex[Pmtl-2, col-12, mec-4::nmat-2(juEx7850)]
Genetic reagent
(C. elegans)
CZ26286: nmat-2(ju1512) I / hT2 I, III;
Pmec-7-GFP(muIs32) II;
Ex[Pmtl-2, col-12, mec-4::nmat-2(juEx7851)]
Genetic reagent
(C. elegans)
CZ26391: jph-1(ok2823) I;
Pmec-7-GFP(muIs32) II
Genetic reagent
(C. elegans)
CZ22032: Pmec-4-GFP(zdIs5) I;
anoh-1(tm4762) III
Genetic reagent
(C. elegans)
CZ22033: Pmec-4-GFP(zdIs5) I;
anoh-2(tm4796) IV
Genetic reagent
(C. elegans)
CZ26325: Pmec-4-GFP(zdIs5) I;
anoh-1(tm4762) III;
anoh-2(tm4796) IV
Genetic reagent
(C. elegans)
CZ26069: Pmec-4-GFP(zdIs5) I;
obr-1(xh16) III
Genetic reagent
(C. elegans)
CZ24555: Pmec-4-GFP(zdIs5) I;
obr-2 (xh17) V
Genetic reagent
(C. elegans)
CZ24556: Pmec-4-GFP(zdIs5) I;
obr-3(tm1087) X
Genetic reagent
(C. elegans)
CZ24557: obr-4(tm1567) I;
Pmec-4-GFP(zdIs5) I
Genetic reagent
(C. elegans)
CZ25696: obr-4(tm1567) I;
Pmec-4-GFP(zdIs5) I;
obr-1(xh16) III; obr-2(xh17) V;
obr-3(tm1087) X
Genetic reagent
(C. elegans)
CZ26375: Pmec-4-GFP(zdIs5) I;
esyt-2(ju1409) III
Genetic reagent
(C. elegans)
CZ26570: juIs540 [Pmec-4-mKate2-ESYT-2];
juEx7807[Pmec-4-GFP-PISY-1]
Genetic reagent
(C. elegans)
CZ24897: juEx7604 [Pmec-4-GFP-ESYT-2]
Genetic reagent
(C. elegans)
CZ22087: Pmec-7-GFP(muIs32) II;
atgl-1(tm3116) III / hT2 I, III
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Genetic reagent
(C. elegans)
CZ22536: Pmec-7-GFP(muIs32) II;
hosl-1(gk278589) X
Genetic reagent
(C. elegans)
CZ22006: Pmec-7-GFP(muIs32) II;
abhd-5.1(ok3722) V
Genetic reagent
(C. elegans)
CZ21968: Pmec-7-GFP(muIs32) II;
abhd-5.2(ok3245) V
Genetic reagent
(C. elegans)
CZ22007: lid-1(gk575511) I;
Pmec-7-GFP(muIs32) II
Genetic reagent
(C. elegans)
CZ22163: Pmec-7-GFP(muIs32) II;
abhd-5.2(ok3245) V abhd-5.1(ju1282) V
Genetic reagent
(C. elegans)
CZ22166: lid-1(gk575511) I;
Pmec-7-GFP(muIs32) II;
abhd-5.2(ok3245) abhd-5.1(ju1282) V
Genetic reagent
(C. elegans)
CZ22686: Pmec-7-GFP(muIs32) II;
lipl-1(tm1954) V
Genetic reagent
(C. elegans)
CZ22688: Pmec-7-GFP(muIs32) II;
lipl-3(tm4498) V
Genetic reagent
(C. elegans)
CZ22535: Pmec-7-GFP(muIs32) II;
lipl-4(tm4417) V
Genetic reagent
(C. elegans)
CZ24364: Pmec-4-GFP(zdIs5) I;
lgg-1(tm3489) II/ mIn1 II
Genetic reagent
(C. elegans)
CZ23325: Pmec-7-GFP(muIs32) II;
lgg-2(tm6474) IV
Genetic reagent
(C. elegans)
CZ23322: Pmec-7-GFP(muIs32) II;
hlh-30(tm1978) IV
Genetic reagent
(C. elegans)
CZ14408: Pmec-7-GFP(muIs32) II;
mxl-3(ok1947) X
Genetic reagent
(C. elegans)
CZ22541: nhr-49(nr2041) I;
Pmec-7-GFP(muIs32) II
Genetic reagent
(C. elegans)
CZ22510: Pmec-7-GFP(muIs32) II;
nhr-80(tm1011) III
Genetic reagent
(C. elegans)
CZ25587: Pmec-4-GFP(zdIs5) I;
cka-1(tm1241) IV
Genetic reagent
(C. elegans)
CZ25549: Pmec-4-GFP(zdIs5) I;
cka-2(tm841) X
Genetic reagent
(C. elegans)
CZ25403: Pmec-4-GFP(zdIs5) I;
cka-1(tm1241) IV; cka-2(tm841) X.
Genetic reagent
(C. elegans)
CZ25370: Pmec-4-GFP(zdIs5) I;
pcyt-1(et9) X
Genetic reagent
(C. elegans)
CZ25790: Pmec-4-GFP(zdIs5) I;
pcyt-2.1(gk440213) I
Genetic reagent
(C. elegans)
CZ25368: Pmec-4-GFP(zdIs5) I;
pcyt-2.2(ok2179) X
Genetic reagent
(C. elegans)
CZ25992: Pmec-4-GFP(zdIs5) I; pcyt-2.1(gk440213) I;
pcyt-2.2(ok2179) X
Genetic reagent
(C. elegans)
CZ26521: Pmec-4-GFP(zdIs5) I; pcyt-2.1(gk440213) I;
pcyt-1(et9) X
Genetic reagent
(C. elegans)
CZ25369: Pmec-4-GFP(zdIs5) I;
cept-1(et10) X
Genetic reagent
(C. elegans)
CZ26423: Pmec-4-GFP(zdIs5) I;
cept-2(ok3135) V
Genetic reagent
(C. elegans)
CZ19835: Pmec-4-GFP(zdIs5) I;
kel-8(tm5214) V
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Genetic reagent
(C. elegans)
CZ23911: kel-20(tm3676) I;
mec-7-GFP(muIs32) II
Genetic reagent
(C. elegans)
CZ18224: Pmec-4-GFP(zdIs5) I;
ivns-1(ok3171) X
Genetic reagent
(C. elegans)
CZ18225: Pmec-4-GFP(zdIs5) I;
ivns-1(gk252) X
Genetic reagent
(C. elegans)
CZ25508: Pmec-4-GFP(zdIs5) I;
ivns-1(ok3171) X;
Ex[ivns-1_gDNA(juEx7673)]
Genetic reagent
(C. elegans)
CZ25509: Pmec-4-GFP(zdIs5) I;
ivns-1(ok3171) X;
Ex[ivns-1_gDNA(juEx7674)]
Genetic reagent
(C. elegans)
CZ25510: Pmec-4-GFP(zdIs5) I;
ivns-1(gk252) X;
Ex[ivns-1_gDNA(juEx7673)]
Genetic reagent
(C. elegans)
CZ25511: Pmec-4-GFP(zdIs5) I;
ivns-1(gk252) X;
Ex[ivns-1_gDNA(juEx7674)]
Genetic reagent
(C. elegans)
CZ24755: juEx7584[Pesyt-2-GFP]
Genetic reagent
(C. elegans)
CZ21465: Pmec-4-GFP(zdIs5) I;
epi-1(gm121) IV
Genetic reagent
(C. elegans)
CZ21463: Pmec-7-GFP(muIs32) II;
emb-9(tk75) III
Genetic reagent
(C. elegans)
CZ21198: Pmec-7-GFP(muIs32) II;
adt-1(cn30) X
Genetic reagent
(C. elegans)
CZ20937: Pmec-4-GFP(zdIs5) I;
adt-2(wk156) X
Genetic reagent
(C. elegans)
CZ21004: Pmec-4-GFP(zdIs5) I;
adt-3 (T19D2.1) (ok923) X
Genetic reagent
(C. elegans)
CZ26611: Pmec-7-GFP(muIs32) II;
gon-1(e1254) IV / +
Genetic reagent
(C. elegans)
CZ23908: rab-8(tm2526) I;
Pmec-7-GFP(muIs32) II
Genetic reagent
(C. elegans)
CZ23909: rab-11.2(tm2081) I;
Pmec-7-GFP(muIs32) II
Genetic reagent
(C. elegans)
CZ20682: Pmec-7-GFP(muIs32) II;
nex-1(gk148) III
Genetic reagent
(C. elegans)
CZ20683: Pmec-7-GFP(muIs32) II;
nex-2(ok764) III
Genetic reagent
(C. elegans)
CZ20684: Pmec-7-GFP(muIs32) II;
nex-3(gk385) III
Genetic reagent
(C. elegans)
CZ20685: Pmec-7-GFP(muIs32) II;
nex-4(gk102) V
Genetic reagent
(C. elegans)
CZ14006: Pmec-7-GFP(muIs32) II;
mec-17(ok2109) IV
Genetic reagent
(C. elegans)
CZ14008: Pmec-7-GFP(muIs32) II;
atat-2(ok2415) X
Genetic reagent
(C. elegans)
CZ14848: mec-17(ok2109) IV; atat-2(ok2415) X;
Pmec-7-GFP(muIs32) II
Genetic reagent
(C. elegans)
CZ17720: Pmec-7-GFP(muIs32) II;
mec-12(tm5083) III
Genetic reagent
(C. elegans)
CZ9247: tba-1(ok1135) I;
Pmec-7-GFP(muIs32) II
Continued on next page
Kim et al. eLife 2018;7:e39756. DOI: https://doi.org/10.7554/eLife.39756 19 of 31
Tools and resources Neuroscience
Continued
Reagent type
(species) or resource Designation Source or reference Identifiers
Additional
information
Genetic reagent
(C. elegans)
CZ26688: Pmec-4-GFP(zdIs5) I;
tba-7(gk787939) III
Genetic reagent
(C. elegans)
CZ26833: Pmec-4-GFP(zdIs5) I;
tba-7(u1015) III
Genetic reagent
(C. elegans)
CZ26635: Pmec-4-GFP(zdIs5) I;
mec-7(ok2152) X
Genetic reagent
(C. elegans)
CZ10615: Pmec-4-GFP(zdIs5) I;
tbb-2(gk129) III
Genetic reagent
(C. elegans)
CZ11083: Pmec-4-GFP(zdIs5) I;
tbb-4(ok1461) X
Genetic reagent
(C. elegans)
CZ10810: Pmec-4-GFP(zdIs5) I;
tbb-6(tm2004) V
Genetic reagent
(C. elegans)
CZ21461: Pmec-4-GFP(zdIs5) I;
fli-1(ky535) III
Genetic reagent
(C. elegans)
CZ21199: Pmec-7-GFP(muIs32) II;
gsnl-1(ok2979) V
Genetic reagent
(C. elegans)
CZ10888: viln-1(ok2413) I;
Pmec-7-GFP(muIs32) II
Genetic reagent
(C. elegans)
CZ13606: Pmec-4-GFP(zdIs5) I;
twf-2(ok3564) X
Genetic reagent
(C. elegans)
CZ20063: Pmec-4-GFP(zdIs5) I;
mfsd-6(ju833) III
Genetic reagent
(C. elegans)
CZ19827: Pmec-4-GFP(zdIs5) I;
mfsd-6(tm3356) III
Genetic reagent
(C. elegans)
CZ24417: Pmec-4-GFP(zdIs5) I;
mfsd-6(tm3356) III;
Prgef-1-mfsd-6(juEx6079)
Genetic reagent
(C. elegans)
CZ21030: Pmec-4-GFP(zdIs5) I;
C05D9.7(ok2931) X
Genetic reagent
(C. elegans)
CZ25317: Pmec-4-GFP(zdIs5) I;
dpy-10(e128) II
Genetic reagent
(C. elegans)
CZ23667: Pmec-4-GFP(zdIs5) I;
F35G2.1(ok1669) IV
Genetic reagent
(C. elegans)
CZ23772: Pmec-4-GFP(zdIs5) I;
gly-2(tm839) I
Genetic reagent
(C. elegans)
CZ17890: Pmec-4-GFP(zdIs5) I;
osm-11(rt142) X
Genetic reagent
(C. elegans)
CZ17021: Pmec-4-GFP(zdIs5) I;
zig-1(ok784) II
Genetic reagent
(C. elegans)
CZ17023: Pmec-4-GFP(zdIs5) I;
zig-3(gk33) X
Genetic reagent
(C. elegans)
CZ17024: Pmec-4-GFP(zdIs5) I;
zig-3(ok1476) X
Genetic reagent
(C. elegans)
CZ22031: abts-1(ok1566) I;
Pmec-7-GFP(muIs32) II
Genetic reagent
(C. elegans)
CZ21461: Pmec-4-GFP(zdIs5) I;
fli-1(ky535) III
Genetic reagent
(C. elegans)
CZ17435: Pmec-7-GFP(muIs32) II;
mec-12(e1605) III
Genetic reagent
(C. elegans)
CZ17637: Pmec-4-GFP(zdIs5) I;
tba-9(ok1858) X
Genetic reagent
(C. elegans)
CZ20033: vab-10(e698) I;
Pmec-7-GFP(muIs32) II
Continued on next page
Kim et al. eLife 2018;7:e39756. DOI: https://doi.org/10.7554/eLife.39756 20 of 31
Tools and resources Neuroscience
Continued
Reagent type
(species) or resource Designation Source or reference Identifiers
Additional
information
Genetic reagent
(C. elegans)
CZ17099: Pmec-4-GFP(zdIs5) I;
plk-1(or683ts) III
Genetic reagent
(C. elegans)
CZ17285: Pmec-4-GFP(zdIs5) I;
svh-2(tm737) X
Genetic reagent
(C. elegans)
CZ19343: Pmec-4-GFP(zdIs5) I;
cpr-1(ok1344) V
Genetic reagent
(C. elegans)
CZ19200:dhhc-11(gk1105) I;
Pmec-7-GFP(muIs32) II
Genetic reagent
(C. elegans)
CZ22823: Pmec-4-GFP(zdIs5) I;
eat-3(tm1107) II
Genetic reagent
(C. elegans)
CZ16134: Pmec-4-GFP(zdIs5) I;
npr-20(ok2575) II
Genetic reagent
(C. elegans)
CZ23845: Pmec-4-GFP(zdIs5) I;
ptps-1(tm1984) I
Genetic reagent
(C. elegans)
CZ17995: supr-1(ju1118) I;
Pmec-7-GFP(muIs32) II
Genetic reagent
(C. elegans)
CZ12031: Pmec-4-GFP(zdIs5) I;
rsef-1(ok1356) X
Genetic reagent
(C. elegans)
CZ17629: Pmec-4-GFP(zdIs5) I;
osm-7(tm2256) III
Genetic reagent
(C. elegans)
CZ17098: Pmec-4-GFP(zdIs5) I;
par-2(or373ts) III
Genetic reagent
(C. elegans)
CZ18676: Pmec-4-GFP(zdIs5) I;
rgl-1(ok1921) X
Genetic reagent
(C. elegans)
CZ20056: Pmec-7-GFP(muIs32) II;
wdfy-3(ok912) IV
Genetic reagent
(C. elegans)
CZ19721: Pmec-4-GFP(zdIs5) I
wdr-23(tm1817) I
Genetic reagent
(C. elegans)
CZ22063: Pmec-4-GFP(zdIs5) I;
brap-2(tm5132) II
Genetic reagent
(C. elegans)
CZ21217: Pmec-4-GFP(zdIs5) I;
brap-2(ok1492) II
Genetic reagent
(C. elegans)
CZ19337: Pmec-4-GFP(zdIs5) I;
cdc-48.1(tm544) II
Genetic reagent
(C. elegans)
CZ19725: Pmec-4-GFP(zdIs5) I;
ced-9(n1950sd) III
Genetic reagent
(C. elegans)
CZ21651: Pmec-4-GFP(zdIs5) I;
dnj-23(tm7102) II
Genetic reagent
(C. elegans)
CZ21356: Pmec-4-GFP(zdIs5) I;
fbxc-50(tm5154) II
Genetic reagent
(C. elegans)
CZ16950: Pmec-7-GFP(muIs32) II;
math-33(ok2974) V
Genetic reagent
(C. elegans)
CZ16951: Pmec-7-GFP(muIs32) II;
skr-5(ok3068) V
Genetic reagent
(C. elegans)
CZ21010: tep-1(tm3720) I;
Pmec-7-GFP(muIs32) II
Genetic reagent
(C. elegans)
CZ22796: mec-8(e398) I;
Pmec-7-GFP(muIs32) II
Genetic reagent
(C. elegans)
CZ14510: Pmec-4-GFP(zdIs5) I;
rict-1(mg360) II
Genetic reagent
(C. elegans)
CZ22570: rtcb-1(gk451) I /
[bli-4(e937) let-?(q782) qIs48](hT2) I, III;
Pmec-7-GFP(muIs32) II
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Genetic reagent
(C. elegans)
CZ21655: Pmec-4-GFP(zdIs5) I;
skn-1(ok2315) IV/nT1(qIs51) IV; V
Genetic reagent
(C. elegans)
CZ23377: Pmec-4-GFP(zdIs5) I;
smg-3(r930) IV
Genetic reagent
(C. elegans)
CZ13997: Pmec-7-GFP(muIs32) II;
syd-9(ju49) X
Genetic reagent
(C. elegans)
CZ21723: Pmec-4-GFP(zdIs5) I;
tdp-1(ok803) II
Genetic reagent
(C. elegans)
CZ23133: Pmec-4-GFP(zdIs5) I;
wdr-5.1(ok1417) III
Genetic reagent
(C. elegans)
CZ21194: Pmec-7-GFP(muIs32) II;
mig-17(k174) V
Genetic reagent
(C. elegans)
CZ22792: Pmec-7-GFP(muIs32) II;
ZC116.3(ok1618) V
Genetic reagent
(C. elegans)
CZ19193: Pmec-7-GFP(muIs32) II;
lgc-12(ok3546) III
Genetic reagent
(C. elegans)
CZ18217: Pmec-4-GFP(zdIs5) I;
tmc-1(ok1859) X
Genetic reagent
(C. elegans)
CZ17639: Pmec-4-GFP(zdIs5) I;
nud-1(ok552) III
Genetic reagent
(C. elegans)
CZ17841: Pmec-4-GFP(zdIs5) I;
mgl-1(tm1811) X
Genetic reagent
(C. elegans)
CZ17843: Pmec-4-GFP(zdIs5) I;
mgl-3(tm1766) IV
Genetic reagent
(C. elegans)
CZ17848: Pmec-4-GFP(zdIs5) I;
npr-25(ok2008) V
Genetic reagent
(C. elegans)
CZ22890: Pmec-4-GFP(zdIs5) I;
ucr-2.3(ok3073) III
Genetic reagent
(C. elegans)
CZ15607: drag-1(tm3773) I;
Pmec-7-GFP(muIs32) II
Genetic reagent
(C. elegans)
CZ17393: Pmec-4-GFP(zdIs5) I;
snb-6(tm5195) II
Genetic reagent
(C. elegans)
CZ17018: Pmec-4-GFP(zdIs5) I;
drag-1(tm3773) I
Genetic reagent
(C. elegans)
CZ18617: Pmec-4-GFP(zdIs5) I;
ect-2(ku427) II
Genetic reagent
(C. elegans)
CZ18818: Pmec-4-GFP(zdIs5) I;
lin-2(e1309) X
Genetic reagent
(C. elegans)
CZ18817: Pmec-4-GFP(zdIs5) I;
magi-1(zh66) IV
Genetic reagent
(C. elegans)
CZ20673: Pmec-4-GFP(zdIs5) I;
prmt-5(gk357) III
Genetic reagent
(C. elegans)
CZ18816: Pmec-4-GFP(zdIs5) I;
rap-1(tm861) IV
Genetic reagent
(C. elegans)
CZ18460: Pmec-4-GFP(zdIs5) I;
smz-1(ok3576) IV
Genetic reagent
(C. elegans)
CZ22544: Pmec-4-GFP(zdIs5) I;
trxr-1(sv47) IV
Genetic reagent
(C. elegans)
CZ24963: Pmec-4-GFP(zdIs5) I;
natb-1(ju1405) V/nT1 IV; V
Genetic reagent
(C. elegans)
CZ16946: Pmec-7-GFP(muIs32) II;
rnf-5(tm794) III
Continued on next page
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Continued
Reagent type
(species) or resource Designation Source or reference Identifiers
Additional
information
Genetic reagent
(C. elegans)
CZ23068: ulp-5/tofu-3(tm3063) I;
Pmec-7-GFP(muIs32) II
Genetic reagent
(C. elegans)
CZ23091: Pmec-7-GFP(muIs32) II;
csr-1(fj54) IV/nT1 IV; V
Genetic reagent
(C. elegans)
CZ17638: Pmec-4-GFP(zdIs5) I;
elpc-3(ok2452) V
Genetic reagent
(C. elegans)
CZ12938: Pmec-4-GFP(zdIs5) I;
hda-6(tm3436) IV
Recombinant
DNA reagent
Plasmid: pCZGY3260:
nmat-2 genomic DNA
This work N/A nmat-2 genomic DNA
(~1500 bp upstream;
~670 bp
downstream);
modified pCFJ201
plasmid
for modified
MosSCI
on ChIV
Recombinant
DNA reagent
Plasmid: pCZ993:
Pmec-4-nmat-2
gDNA-let-858 3’UTR
This work N/A nmat-2 expression
driven by mec-4
promoter in the
mechanosensory
neurons
Recombinant
DNA reagent
Plasmid: pCZ994:
Pmtl-2-nmat-2
gDNA-let-858 3’UTR
This work N/A nmat-2 expression
driven by mtl-2
promoter in the
intestine
Recombinant
DNA reagent
Plasmid: pCZ995:
Pcol-12-nmat-2 g
DNA-let-858 3’UTR
This work N/A nmat-2 expression
driven by col-12
promoter in the
epiderdims
Recombinant
DNA reagent
Plasmid: pCZGY3329:
Pmec-4-GFP-ESYT-2
This work N/A
Recombinant
DNA reagent
Plasmid: pCZGY3344:
Pmec-4-mKate2-ESYT-2
This work N/A
Recombinant
DNA reagent
Plasmid: pCZGY3342:
Pmec-4-mKate2-PISY-1
This work N/A
Recombinant
DNA reagent
Plasmid: pCZGY3302:
ivns-1 genomic DNA
This work N/A ivns-1 genomic DNA
(2 kb upstream;
800 bp
downstream)
Recombinant
DNA reagent
Plasmid: pCZGY3347:
Prgef-1-mfsd-6
This work N/A
Recombinant
DNA reagent
Plasmid: pCZGY3346:
Pesyt-2-GFP
This work N/A GFP expression
driven by esyt-2
promoter
Sequence-
based reagent
crRNA: nmat-2:/AltR1/rCrG
rArGrU rCrGrC rUrCrU
rUrCrU rUrGrC rCrGrU
rGrUrU rUrUrA rGrArG
rCrUrA rUrGrC rU/AltR2/
IDT N/A crRNA to make
nmat-2(ju1512)
and nmat-
2(ju1514)
Sequence-
based reagent
crRNA: nmat-2:/AltR1/rCrG
rUrGrU rUrGrA rArCrU
rArArC
rUrCrC rArCrU rGrUrU
rUrUrA rGrArG rCrUrA
rUrGrC rU/AltR2/
IDT N/A crRNA to make
nmat-2(ju1512)
Continued on next page
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Continued
Reagent type
(species) or resource Designation Source or reference Identifiers
Additional
information
Sequence-
based reagent
crRNA: nmat-1:/AltR1/rArA
rCrUrU rUrUrU rCrGrG
rUrCrC rCrCrA rUrArG
rGrUrU rUrUrA rGrArG
rCrUrA rUrGrC rU/AltR2/
IDT N/A crRNA to mak
e nmat-1
(ju1565)
Sequence-
based reagent
crRNA: nmat-1:/AltR1/rArU
rGrUrA rCrUrU rGrArU rUrArC
rGrGrA rArUrC rGrUrU
rUrUrA rGrArG rCrUrA
rUrGrC rU/AltR2/
IDT N/A crRNA to make
nmat-1(ju1565)
Sequence-
based reagent
crRNA: qns-1:/AltR1/rGrG
rUrGrU rUrArU rUrCrA
rCrGrU rGrUrU rArCrA
rGrUrU rUrUrA rGrArG
rCrUrA rUrGrC rU/AltR2/
IDT N/A crRNA to make
qns-1(ju1563)
Sequence-
based reagent
crRNA: qns-1:/AltR1/rGrA
rUrArA rCrUrG rArArA rUrCrU
rGrGrA rUrArG rGrUrU rUrUrA
rGrArG rCrUrA
rUrGrC rU/AltR2/
IDT N/A crRNA to make
qns-1(ju1563)
Sequence-
based reagent
crRNA: esyt-2:/AltR1/rGrG
rUrUrU rCrArG rUrArA rUrUrG
rUrGrG rGrCrU rGrUrU
rUrUrA rGrArG rCrUrA
rUrGrC rU/AltR2/
IDT N/A crRNA to make
esyt-2(ju1409)
Sequence-
based reagent
crRNA: esyt-2:/AltR1/rGrU
rGrCrA rCrUrU rArCrG
rGrGrU rUrGrU rArGrG
rGrUrU rUrUrA rGrArG
rCrUrA rUrGrC rU/AltR2/
IDT N/A crRNA to make
esyt-2(ju1409)
Peptide,
recombinant
protein
Protein: Cas9-NLS
purified protein
QB3
MacroLab,
UC Berkley
N/A
Peptide,
recombinant
protein
Phusion High-Fidelity
DNA polymerases
Thermo
Scientific
Cat#F530L
Peptide,
recombinant
protein
DreamTaq
DNA polymerases
Thermo
Scientific
Cat#EP0705
Commercial
assay or kit
Chemical
compound, drug
5-fluoro-2-deoxy
uridine
Sigma-Aldrich Cat#50-91-9
Software,
algorithm
ImageJ NIH image RRID:
SCR_003070
Software,
algorithm
ZEN Zeiss https://www.zeiss.
com/
microscopy/us/
downloads/
zen.html
Software,
algorithm
Zeiss LSM Data
Server
Zeiss https://www.zeiss
.com
/microscopy/us/
downloads/
lsm-5-series.html
Software,
algorithm
GraphPad
Prism 5
GraphPad
Software, Inc.
RRID:SCR_002798
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Experimental model
The nematode Caenorhabditis elegans was used as the experimental model for this study. All
experiments were performed with hermaphrodite animals; males were used only for crosses. Unless
otherwise indicated, all experiments were carried out with L4 stage animals. Strains were maintained
under standard conditions on Nematode Growth Media (NGM) plates seeded with E. coli OP50 bac-
teria unless mentioned. Wild type was the N2 Bristol strain (Brenner, 1974). New strains were con-
structed using standard procedures and all genotypes confirmed by PCR or sequencing.
Extrachromosomal array transgenic lines were generated as described (Mello et al., 1991).
Laser microsurgery of axons (axotomy)
We cut PLM axons and quantified the length of regrown axons as previously described (Wu et al.,
2007).
Axotomy imaging with MicroPoint laser
L4 stage animals were immobilized using 2.5 mM levamisole in M9 buffer on 5% agar pads. Using a
MicroPoint laser on an Andor spinning disk confocal unit (CSU-W1) with Leica DMi8 microscope,
laser axotomy was performed on the PLM axon ~45 mm away from the cell body. Images were taken
immediately before and immediately after axotomy (0.81 s) with iXon ultra 888 EMCCD camera.
Confocal imaging with Airyscan
L4 stage animals were immobilized using 2.5 mM levamisole in M9 buffer on 5% agar pads. PLM
mechanosensory neuron cell bodies were imaged using a Zeiss LSM800 equipped with Airyscan.
Z-stack planes were taken at 0.2 mm intervals in both mKate2 and GFP channels using Airyscan.
CRISPR-Cas9 gene editing
We generated the nmat-2(ju1512), nmat-1(ju1564), qns-1(ju1563), and esyt-2(ju1409) deletion alleles
using co-CRISPR (Arribere et al., 2014; Friedland et al., 2013). We generated the nmat-2(ju1514)
point mutation allele using the homology-directed genome editing and single-strand oligodeoxynu-
cleotide repair method (Paix et al., 2017).
FUdR treatment
We transferred worms onto plates containing 50 mg/ml 5-fluoro-2-deoxy uridine (FUdR) immediately
after axotomy. No offspring were observed after 2 days, confirming FUDR-induced sterility.
Quantification and statistical analysis
Statistical analysis was performed using GraphPad Prism 5. Significance was determined using
unpaired t-tests for two samples, one-way ANOVA followed by multiple comparison tests for multi-
ple samples. p<0.05 (*) was considered statistically significant. *p<0.05; **p<0.01; ***p<0.001. Data
are shown as mean ± SEM. ‘n’ represents the number of animals and is shown in graphs.
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